LifeScience Biologics

IMBdx Expands Targeted Therapies Agreement after Successful Prostate Cancer Genomic Profiling

The collaboration aims to improve accessibility to targeted therapies for mCRPC patients in international markets outside the US. Traditional tissue biopsi...

 June 09, 2023 | News

GeneTex Launches MS Validated PD-L1 Antibody for Immunohistochemistry

The interaction between PD-L1 (CD274/B7-H1) and its receptor programmed death-1 (PD-1) is not only a focus of cancer immunotherapy research but also has ma...

 June 08, 2023 | News

ACROBiosystems Broadens Custom GMP-grade Protein Services for CGT Advancement and Commercialization

To support the commercialization of cell therapies, ACROBiosystems is now offering a global custom GMP-grade protein services. As part of their service pla...

 June 08, 2023 | News

Thermo Fisher Scientific Introduces Groundbreaking Mass Spectrometer to Revolutionize Biological Discovery

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today unveiled the Thermo Scientific™ Orbitrap™ Astral&tra...

 June 07, 2023 | News

Samsung Biologics Hastens Timeline for New Plant, Aiming for April 2025 Launch

Samsung Biologics will maintain the world's largest biomanufacturing capacity at 784,000 liters upon completion of the newest plant- Key features of Plant ...

 June 07, 2023 | News

Acepodia Secures $100 Million Series D Financing to Advance

Series D led by Digital Mobile Venture with participation from additional existing investors Funds will support expansion and progress of oncology pipelin...

 June 07, 2023 | News

Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering

Lonza to acquire Synaffix B.V., an innovative biotech company focused on antibody-drug conjugates (ADCs) Acquisition will further strengthen Lonza&rsquo...

 June 05, 2023 | News

WuXi Biologics to Increase Manufacturing Capacity in Germany

-  The investment promotes the creation of additional high-skilled jobs -  As part of WuXi Biologics' global manufacturing network, a new drug p...

 June 02, 2023 | News

Keio and Osaka Universities Present Non-Clinical Data on Stable/Functional-Induced Regulatory T Cells in Autoimmune Models

Their presentation demonstrated that in a murine pemphigus model, S/F-iTregs significantly decreased clinical scores, circulating anti-Dsg3 IgG titers, and...

 May 30, 2023 | News

Novo Nordisk and Life Edit Therapeutics collaborate on gene editing therapies for rare and cardiometabolic diseases

Life Edit has the option to a global profit share on one programme. Novo Nordisk will make an equity investment in ElevateBio, Li...

 May 29, 2023 | News

HanAll Biopharma, Daewoong Pharmaceutical, and NurrOn Pharma Collaborate on Parkinson's Therapy

HanAll Biopharma Co., Ltd. (KRX: 009420.KS) and Daewoong Pharmaceutical Co., Ltd. (KRX: 069620.KS) announced that they have entered into a co-developm...

 May 26, 2023 | News

Leading New Zealand Cancer Research Gets a Data Privacy Boost with Amaroq Therapeutics and GeneCrypt Partnership

Amaroq Therapeutics, a world-leading company based in New Zealand focused on developing a new class of therapeutics that targets long non-coding ...

 May 26, 2023 | News

Oncodesign and Veritas In Silico Collaborate on mRNA-Targeted Drug Development

The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional pro...

 May 25, 2023 | News

10x Genomics Launches Visium CytAssist Gene and Protein Expression Assay

 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of a new Visium CytAs...

 May 25, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close